| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 | SCHEDULE 13G |
| 03 Nov 2026 | S-8 |
| 03 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
Aliso Viejo, Calif. – November 3, 2026 – RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026. |
| 02 Nov 2026 | SCHEDULE 13G/A |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 16 Sep 2026 |
Form 4: Weinberg Eric, See remarks
Received 35,168 shares by exercise or conversion ($153K) |
| 09 Sep 2026 |
Form 4: Wilterding Mark, Chief Financial Officer
Disposed of 258,770 Stock Option (right to buy) (Disposition to Issuer) · Granted 258,770 Stock Option (right to buy) |
| 09 Sep 2026 |
Form 4: Weinberg Eric, See remarks
Disposed of 87,437 Stock option (right to buy) (Disposition to Issuer) · Disposed of 362,200 Stock Option (right to buy) (Disposition to Issuer) · Granted 334,075 Stock Option (right to buy) |
| 09 Sep 2026 |
Form 4: Kurtz Ronald M Md, Chief Medical Officer
Disposed of 338,819 Stock option (right to buy) (Disposition to Issuer) · Disposed of 564,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 686,447 Stock Option (right to buy) |
| 09 Sep 2026 |
Form 4: Goldshleger Ilya, Chief Operating Officer
Disposed of 98,367 Stock option (right to buy) (Disposition to Issuer) · Disposed of 387,200 Stock Option (right to buy) (Disposition to Issuer) · Granted 364,032 Stock Option (right to buy) |
| 08 Sep 2026 | SC TO-I/A |
| 02 Sep 2026 | 144 |
| 02 Sep 2026 | 144 |
| 02 Sep 2026 | 144 |
| 02 Sep 2026 | 144 |
| 02 Sep 2026 |
Form 4: Kurtz Ronald M Md, Chief Medical Officer
Received 13,425 shares by exercise or conversion · Sold 5,100 shares ($35.5K) |
| 02 Sep 2026 |
Form 4: Wilterding Mark, Chief Financial Officer
Received 20,441 shares by exercise or conversion · Sold 7,765 shares ($54K) |
Loading...